April 2, 2007 — Mount Sinai Medical Center, Miami Beach, FL, has implanted one of the first of a new device intended to strengthen the heartbeat of patients with heart failure. The pacemaker-like device called the Optimizer System is a pulse generator designed to deliver electrical impulses to the heart for treatment of moderate to severe heart failure.

April 2, 2007 — CardioMEMS Inc. has announced the FDA has cleared the EndoSure AAA Wireless Pressure Measurement System for measuring intrasac pressure during thoracic aortic aneurysm (TAA) repair.

April 2, 2007 — Cordis Corp. has announced today the start of the pivotal trial for the ExoSeal Vascular Closure Device. The ECLIPSE Trial is a multicenter, non-blinded, randomized study designed to measure the safety and efficacy of the ExoSeal Vascular Closure Device versus manual compression to close vascular access sites in patients having undergone diagnostic or interventional procedures.

The trial will encompass 400 patients from 18 medical centers across the U.S.

The ImageGrid by Candelis Inc. is a line of Digital Imaging and Communications in Medicine (DICOM) industry-standard PACS appliances optimized for digital-image access and routing. It provides simplified image management and highly reliable storage and archive capabilities in a fully-integrated storage server platform.

The ImageGrid by Candelis Inc. is a line of Digital Imaging and Communications in Medicine (DICOM) industry-standard PACS appliances optimized for digital-image access and routing. It provides simplified image management and highly reliable storage and archive capabilities in a fully-integrated storage server platform.

Scottcare Corp. announced that Centers for Medicare and Medicaid Services (CMS) has significantly increased reimbursement levels for external counterpulsation (ECP) therapy. While 2007 Medicare physician payments for cardiology overall dropped by 2 percent, ECP merited a 6.3 percent increase. As a result, the new 2007 national average physician reimbursement for ECP therapy increased to $147 per one-hour session and $5,160 for the complete course of treatment.

McKesson’s Horizon Cardiology is a complete cardiovascular information solution for cath, hemodynamic monitoring, echocardiography, vascular ultrasound and nuclear cardiology. It meets the full spectrum of needs for healthcare organizations with diagnostic digital image management, archiving, procedure reporting and workflow management.

The company introduced version 11.2 during the ACC, which features total Web accessibility and many enhanced features.

PressureWire Certus from RADI represents a paradigm shift in pressure guidewire design with handling characteristics comparable to those of any other high performance guidewire on the market. This means that guiding interventions using FFR is no longer a compromise. PressureWire Certus is a smooth tracking high-performance guidewire with these features:

Cardiac Science Corp.’s Pyramis ECG Data Management System centralizes diagnostic, hospital ECG data to provide instant electronic access to this information at any time or from any location. By automating and streamlining the storage, editing, retrieval and sharing of patient cardiology data including resting ECGs, stress tests, Holter tests, and 12-lead ECGs from bedside monitors, Pyramis helps increase workplace productivity and efficiency within hospitals and physician offices to provide enhanced patient care.

Two-year results presented at ACC from the Medtronic ENDEAVOR III trial confirm the positive clinical profile of the Endeavor drug-eluting coronary stent. Nearly 1,300 Endeavor patients have had at least two years of follow-up, none of whom have developed late stent thrombosis based on independent, pre-specified clinical trial protocol definitions for thrombosis.

Subscribe Now